FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

36924411000001102: Ranitidine 300mg tablets (Relonchem Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113261401000001111 Ranitidine 300mg tablets (Relonchem Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113261501000001110 Ranitidine 300mg tablets (Relonchem Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 300mg tablets (Relonchem Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has precise active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier 1
Ranitidine 300mg tablets (Relonchem Ltd) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (Relonchem Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine 300mg tablets (Relonchem Ltd) 30 tablet Has AMP True Ranitidine 300mg tablets (Relonchem Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start